...
首页> 外文期刊>Antioxidants and redox signalling >Interaction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery Patients
【24h】

Interaction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery Patients

机译:MIF家族蛋白在心肌缺血/再灌注损伤中的相互作用及其对心脏手术患者临床疗效的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Cardiac surgery involves myocardial ischemia/reperfusion (I/R) with potentially deleterious consequences. Macrophage migration inhibitory factor (MIF) is a stress-regulating chemokine-like cytokine that protects against I/R damage, but functional links with its homolog, d-dopachrome tautomerase (MIF-2), and the circulating soluble receptor CD74 (sCD74) are unknown. In this study, we investigate the role of MIF, MIF-2, sCD74, and MIF genotypes in patients scheduled for elective single or complex surgical procedures such as coronary artery bypass grafting or valve replacement. Results: MIF and MIF-2 levels significantly increased intraoperatively, whereas measured sCD74 decreased correspondingly. Circulating sCD74/MIF complexes were detectable in 50% of patients and enhanced MIF antioxidant activity. Intraoperative MIF levels were independently associated with a reduced risk for the development of atrial fibrillation (AF) (odds ratio 0.99 [0.98-1.00]; p=0.007). Circulating levels of MIF-2, but not MIF, were associated with an increased frequency of organ dysfunction and predicted the occurrence of AF (area under the curve [AUC]=0.663; p=0.041) and pneumonia (AUC=0.708; p=0.040). Patients with a high-expression MIF genotype exhibited a reduced incidence of organ dysfunction compared with patients with low-expression MIF genotypes (3 vs. 25; p=0.042). Innovation: The current study comprehensively highlights the kinetics and clinical relevance of MIF family proteins and the MIF genotype in cardiac surgery patients. Conclusion: Our findings suggest that increased MIF levels during cardiac surgery feature organ-protective properties during myocardial I/R, while the soluble MIF receptor, sCD74, may enhance MIF antioxidant activity. In contrast, high MIF-2 levels are predictive of the development of organ dysfunction. Importantly, we provide first evidence for a gene-phenotype relationship between variant MIF alleles and clinical outcome in cardiac surgery patients. Antioxid. Redox Signal. 23, 865-879.
机译:目的:心脏外科手术涉及心肌缺血/再灌注(I / R),并可能造成有害后果。巨噬细胞迁移抑制因子(MIF)是一种抗应激的趋化因子样细胞因子,具有抗I / R损伤的功能,但与它的同系物d-dopachrome互变异构酶(MIF-2)和循环可溶性受体CD74(sCD74)具有功能联系未知。在这项研究中,我们调查了MIF,MIF-2,sCD74和MIF基因型在计划进行选择性单次或复杂外科手术(例如冠状动脉搭桥术或瓣膜置换术)的患者中的作用。结果:术中MIF和MIF-2水平显着升高,而所测sCD74相应降低。在50%的患者中可检测到循环中的sCD74 / MIF复合物,并增强了MIF的抗氧化活性。术中MIF水平与降低房颤(AF)的风险独立相关(比值0.99 [0.98-1.00]; p = 0.007)。 MIF-2而不是MIF的循环水平与器官功能障碍的发生频率增加相关,并预测了AF(曲线下面积[AUC] = 0.663; p = 0.041)和肺炎(AUC = 0.708; p = 0.040)。与低表达MIF基因型患者相比,高表达MIF基因型患者的器官功能障碍发生率降低(3比25; p = 0.042)。创新:当前的研究全面强调了心脏手术患者中MIF家族蛋白的动力学和临床意义以及MIF基因型。结论:我们的研究结果表明,心脏手术中MIF水平升高在心肌I / R期间具有器官保护特性,而可溶性MIF受体sCD74可能会增强MIF的抗氧化活性。相反,高MIF-2水平可预测器官功能障碍的发展。重要的是,我们提供了心脏手术患者中变异MIF等位基因与临床结局之间基因表型关系的第一个证据。抗氧化。氧化还原信号。 23,865-879。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号